The Journal of Pathology · 2006 · 39 citations · 24 references
Life SciencesImmunologyPathologyAutoimmunityImmunopathologyInflammationAutoimmune DiseasesCellular Immune ResponsesImmunodeficiency DisordersLeukocyte DisordersLymphoid Tissue PathologyPrimary ImmunodeficiencyB-cell DisordersCell-mediated Immunity DefectsX-linked Immunodeficiency
The Wiskott-Aldrich syndrome (WAS) is an X-linked immunodeficiency syndrome caused by mutations in the WAS protein (WASP). This participates in signalling and cytoskeletal homoeostasis, and some of its activities are regulated by its binding to the WASP interacting protein (WIP). WIP deficiency, however, has not yet been shown to be of pathological significance in humans. Here we show that, in WIP null (WIP(-/-)) mice, it produces haematological alterations and anatomical abnormalities in several organs, most probably as a consequence of autoimmune attacks. Granulocytosis and severe lymphopenia are associated with a proportional increase in segmented cells and fewer bone marrow erythrocytes and lymphocytes. Splenomegaly is accompanied by an increase of haematopoietic tissue and red pulp, reduction of the white pulp, and fewer B (B220(+)) lymphocytes (also apparent in the lymph nodes and Peyer's patches). Ulcerative colitis, interstitial pneumonitis, glomerular nephropathy with IgA deposits, autoantibodies, and joint inflammation are also evident. These progressive immunological disorders closely mimic those seen in WAS. WIP deficiency may thus be implicated in some cases in which mutations in the gene encoding WASP are not detected.
24
Isolation of a novel gene mutated in Wiskott-Aldrich syndrome
Jonathan M.J. Derry, Hans D. Ochs, Uta Francke · Cell · 1994 · 1.1K citations
Narayanaswamy Ramesh, Inés M. Antón, John H. Hartwig et al. · Proceedings of the National Academy of Sciences · 1997 · 378 citations
The Primary Immunodeficiencies
Fred S. Rosen, Max D. Cooper, Ralph Wedgwood · New England Journal of Medicine · 1995 · 323 citations